
Study Questions Use of Migraine Meds in Kids, Teens
THURSDAY, Oct. 27, 2016 (HealthDay News) -- A new study raises questions about the effectiveness of medicines commonly prescribed to prevent migraines in children and teens.
The 24-week clinical trial involving 328 patients found no significant differences between the drugs amitriptyline (Elavil), topiramate (Topamax) and a placebo sugar pill in reducing the number of days with a migraine or migraine-related disability.
Fifty-two percent of those taking amitriptyline and 55 percent of those taking topiramate saw the number of days they had a headache drop by 50 percent or more, while 61 percent of those taking a placebo pill saw the same benefit, the findings showed.
The patients taking the prescription drugs also had much higher rates of side effects, such as fatigue, dry mouth, mood changes, and tingling in the hands, arms, legs or feet.
"The study was intended to demonstrate which of the commonly used preventive medications in migraine was the most effective. What we found is that we could prevent these headaches with either a medication or a placebo," said senior study author Dr. Andrew Hershey. He is co-director of the Headache Center at Cincinnati Children's Hospital Medical Center.
"This study suggests that a multidisciplinary approach and the expectation of response is the most important, not necessarily the prescription provided," he added in a hospital news release.
The researchers were "hoping to develop evidence to drive the choice by medical providers of the first-line prevention medication for helping youth with migraine, but the data showed otherwise," said study first author Scott Powers. He is a pediatric psychologist and co-director of the Headache Center.
"We see this as an important opportunity for health care providers, scientists, children and families, because our findings suggest a paradigm shift," Powers said.
"First-line prevention treatment will involve a multidisciplinary team approach and focus on non-pharmacological aspects of care. The good news is we can help children with migraines get better," Powers said.
The findings were published Oct. 27 in the New England Journal of Medicine.
-- Robert Preidt
Article Credits / Source
Sponsored Product
More Migraine Headaches Articles
Migraine and Stroke Risk Linked Again0
TUESDAY, Nov. 15, 2016 (HealthDay News) -- Women who experience migraines have more than double the risk of suffering a stroke, new research shows. The finding adds evidence to the suspected link between these two conditions. Although it's not ...
More Kids and Teens Heading to ER With Headaches0
FRIDAY, Oct. 21, 2016 (HealthDay News) -- A growing number of American children with headaches are being seen at pediatric emergency departments and admitted to the hospital, researchers report. The researchers at the Children's Hospital of ...
Mouth and Gut Germs May Be Linked to Migraines0
TUESDAY, Oct. 18, 2016 (HealthDay News) -- People with migraines have higher levels of certain microbes, or germs, in their mouths and digestive systems, new research suggests. Specifically, the analysis of data from the American Gut Project ...
For Migraine Sufferers, Is a Chiropractor's Touch All in the Mind?0
TUESDAY, Oct. 11, 2016 (HealthDay News) -- People with migraines sometimes seek a chiropractor for help, but a small study suggests that any pain relief they get might be a placebo effect. When researchers pitted real chiropractic manipulation ...
Ketamine May Treat Migraine, Chronic Pain0
By Pauline Anderson Reviewed by Arefa Cassoobhoy, MD, MPH Sept. 28, 2016 -- Ketamine, typically thought of as an anesthesia medicine or even a club drug, is now generating a lot of interest among pain management ...
0 Comments
Write a Comment
Tag Cloud
Our Mailing List
Subscribe to our mailing list to get the latest health news as it breaks!
Author
The full comment or 255 characters
View Article➦